<p>➀ Intel is strategically planning changes to its product roadmap.</p><p>➁ ST is looking to cut jobs due to weak auto and industrial markets.</p><p>➂ Caltech and UCLA have developed a method for mass-producing bio-sensors with antibody-like chemical selectivity.</p>
Related Articles
- Intel Holiday Bundle Gifts Battlefield 6 Or Another AAA Game With These CPUsabout 16 hours ago
 - Intel Reportedly Eyes Retired TSMC Veteran Wei-Jen Lo to Lead R&D5 days ago
 - Intel Reaffirms 14A, Deepens Nvidia Alliance9 days ago
 - Intel's pivotal 18A process is making steady progress, but still lags behind — yields only set to reach industry standard levels in 202711 days ago
 - Intel posts return to growth and profitability in Q3 2025, but significant challenges remain — achieves $13.7 billion revenue with $4.1 billion operating profit11 days ago
 - Trump administration to follow up Intel stake with investment in quantum computing, report claims — tens of millions of CHIPS Act dollars could be paid out to leading companies in exchange for equity12 days ago
 - Trump says Intel has made a 'fortune' and America has made $40 billion after the US invested in ailing chipmaker — Intel has gained $73 billion in market cap since investment14 days ago
 - TSMC to break ground on 1.4nm fab on Nov 5th14 days ago
 - ULTA Beauty: The International Expansion Plan Is Taking Shape25 days ago
 - How the Father of FinFETs Helped Save Moore’s Law28 days ago